Skip to main content
UCL Ventures Navigate back to homepage
Find your Business Manager

Main navigation

  • Your route to market

    Your route to market

    We guide UCL academics, researchers and clinicians to get their research to market.

    Disclose an idea
    • Getting started An introduction to commercialisation and next steps
    • Our collaborative approach How we work with you to get to market
    • What you can expect Demystifying the process of commercialisation
    • Options to move forwards Explore the different pathways to market
      • Protect your idea
      • Create a company
      • Licensing your invention
      • Routes to social impact
    • Funding & support The financial and practical help that we can offer
      • Help managing your project
      • Training & tools
      • Common questions
  • Explore innovations

    Explore innovations

    Our portfolio and technologies span AI and quantum, to gene therapies to consumer products.

    • Spinout portfolio Browse our portfolio of spinout companies, based on UCL research
    • Our expertise & pipeline The sectors we span and therapeutics in development
    • Social Ventures Ventures driving impact in communities
    • License a technology Opportunities & collaborations with UCL's world-class research
  • Global impact

    Global impact

    How UCL research is changing the way the world lives, works and thrives.

    • Inspiring stories Real-world impact and successes, supported by UCL Ventures
    • Impact Report Our annual report showcases how UCL research is going beyond the university
    • Supporting innovation at UCL Understand our role in the innovation ecosystem
  • Investors & business

    Investors & business

    Opportunities for collaboration across UCL's world-class research.

    • Why partner with UCL Ventures With over 30 years in commercialisation, we have a strong track record
    • Our portfolio View our spinout companies across all sectors
  • News & events

    News & events

    The latest news and events from our team and portfolio.

    • News & views Stay up to date with the latest insights and announcements
    • Events Where you can find us across UCL and external events
  • Get in touch

    Get in touch

    Contact our team of experts for all your queries and needs.

    • Speak to the team Choose your enquiry type to reach the right team
Find your Business Manager

UCL’s life sciences expertise showcased at London Life Sciences Week

Spinouts pitched their healthcare innovations to a global community of investors.

20 November 2026

Echopoint medical pitching at London Life Sciences Week 2026

Breadcrumb trail

  1. Home
  2. News & views
  3. UCL’s life sciences expertise showcased at London Life Sciences Week

Entrepreneurs from early-stage spinouts across London’s universities came together for the New Frontiers Showcase on 18 November, providing an opportunity to pitch their innovations to the investment community and celebrate the capital’s strength in life sciences. 

The showcase explored three major trends shaping the sector: London’s ability to turn scientific discovery into commercial success, its position at the forefront of AI-driven life sciences innovation, and the role of the city’s specialised innovation clusters in supporting growth. 

Echopoint medical pitching at London Life Sciences Week 2026
Echopoint's Anthony Odell during their pitch 

Representing UCL were two spinouts developing technologies with the potential to improve the diagnosis and treatment of patients:

  • Eye2Gene has created an AI-powered precision ophthalmology platform, combining imaging and genomics to help eye care professionals speed up the diagnosis of inherited retinal diseases, getting sight-saving treatments to patients earlier.  
  • Echopoint Medical Ltd is developing fibre optic-based microcathers to provide a complete picture of heart physiology, helping clinicians make quicker and better-informed cardiovascular treatment decisions.  
Eye2Gene pitching at London Life Sciences Week 2026
Co-founder and CEO, Dr Nikola Pontikos, pitching for Eye2Gene

UCL Ventures’ CEO, Dr Anne Lane, also contributed to the event, sharing her insights in a keynote address. She reflected on the importance of bringing together researchers, entrepreneurs and investors to help promising life sciences innovations progress towards real-world impact. 

Dr Lane commented: “London has an extraordinary life sciences ecosystem, bringing together world-leading research, entrepreneurial talent and an active investment community. Events like London Life Sciences Week give us an important opportunity to celebrate that strength and, crucially, to connect promising new ventures with the people who can help them grow. It was fantastic to see UCL spinouts showcasing how research and innovation can be translated into technologies with the potential to make a real difference to patients.” 

Over 300 investors from around the world signed up to attend the New Frontiers showcase from leading companies including Albion, Barclays Innovation Banking, Mishcon De Reya, Twinpath Ventures and Corallia Ventures. 

The event built on the success of a similar showcase during 2025 London Life Sciences Week, at which newly-formed UCL spinout BiotaLife presented. Since then, Biotalife has gone on to refocus its business plan and developed and launched its first consumer product ‘Bloomcalma’ - a specialist microbiome-friendly intimate moisturiser designed for women to use in both pregnancy and following childbirth.   

UCL Ventures footer

About UCL Ventures

  • Our people
  • What we do
  • Who we are
  • Our culture

Forms & Resources

  • Publications and downloads

Accreditations

  • Cyber essentials
    cyber essentials logo
  • Living wage
    living wage employer logo
UCL Ventures

UCL Ventures Limited (Company Registration No: 02776963) is a wholly-owned subsidiary of University College London. 

Registered office: 
University College London
Gower Street
London
WC1E 6BT

UCL social media menu

  • Link to Linkedin
Back to top

Legal

  • Cookie policy
  • Freedom of information
  • Privacy policy
  • Rules of website use

© 2026 UCL Ventures Limited